The codependence of angiogenesis and chronic inflammation

Angiogenesis is the growth of new blood vessels from existing ones. It is an important aspect of new tissue development, growth, and tissue repair. It is also a component of many diseases including cancer, blindness, and chronic inflammation such as rheumatoid arthritis (RA) and psoriasis. There is considerable evidence to suggest that angiogenesis and chronic inflammation are codependent; recent studies have begun to reveal the nature of this link, which involves both augmentation of cellular infiltration and proliferation and overlapping roles of regulatory growth factors and cytokines. Through these studies, we have begun to understand the codependence of chronic inflammation and angiogenesis, the potential benefits of targeting angiogenesis in the treatment of chronic inflammation, and of targeting chronic inflammation to affect angiogenesis.—Jackson, J. R., Seed, M. P., Kircher, C., Willoughby, D. A., Winkler, J. D. The codependence of angiogenesis and chronic inflammation. FASEB J. 11, 457–465 (1997)

[1]  S. Abdulla.  Angiogenesis and inflammation , 1999 .

[2]  P. Colville-Nash,et al.  THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN A MURINE CHRONIC GRANULOMATOUS TISSUE AIR POUCH MODEL OF ANGIOGENESIS , 1996, The Journal of pathology.

[3]  K. Yasui,et al.  Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants , 1996, British journal of pharmacology.

[4]  G. Neufeld,et al.  Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor (*) , 1996, The Journal of Biological Chemistry.

[5]  E. Brahn,et al.  Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF). , 1995, Cellular immunology.

[6]  L. Crofford,et al.  Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis , 1995, FEBS letters.

[7]  J. Brown,et al.  The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. , 1995, The Journal of pharmacology and experimental therapeutics.

[8]  T. Ishiwata,et al.  Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. , 1995, The Journal of rheumatology.

[9]  A. Koch,et al.  Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 , 1995, Nature.

[10]  C. Hawkey,et al.  Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs. , 1995, Gut.

[11]  Thomas N. Sato,et al.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.

[12]  J. Rossant,et al.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.

[13]  G. Camussi,et al.  Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. , 1995, Journal of immunology.

[14]  A. Stan,et al.  In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor. , 1995, Journal of neurosurgery.

[15]  J. Slavin,et al.  Fibroblast growth factors: at the heart of angiogenesis. , 1995, Cell biology international.

[16]  D. Willoughby,et al.  Angiostasis and Vascular Regression in Chronic Granulomatous Inflammation Induced by Diclofenac in Combination with Hyaluronan in Mice , 1995, The Journal of pharmacy and pharmacology.

[17]  E. Scanziani,et al.  Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. , 1995, Journal of the National Cancer Institute.

[18]  E. Brahn,et al.  A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. , 1995, Cellular immunology.

[19]  T. Fan,et al.  Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. , 1995, Trends in pharmacological sciences.

[20]  M. Neeman,et al.  Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  V. Castronovo,et al.  Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis. , 1995, Journal of the National Cancer Institute.

[22]  D. Cheresh,et al.  Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.

[23]  S. Nicosia,et al.  Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. , 1994, The American journal of pathology.

[24]  W. A. Galloway,et al.  Preclinical Antiarthritic Activity of Matrix Metalloproteinase Inhibitors , 1994, Annals of the New York Academy of Sciences.

[25]  D. Grobelny,et al.  Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide. , 1994, Cancer research.

[26]  R. Nicosia,et al.  Paracrine interactions between fibroblasts and endothelial cells in a serum-free coculture model. Modulation of angiogenesis and collagen gel contraction. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[27]  V. Dixit,et al.  Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. , 1994, The American journal of pathology.

[28]  Cord Sunderkötter,et al.  Macrophages and angiogenesis , 1994, Journal of leukocyte biology.

[29]  D. Ingber,et al.  Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). , 1994, British Journal of Cancer.

[30]  E. Spisni,et al.  Involvement of prostanoids in the regulation of angiogenesis by polypeptide growth factors. , 1992, Prostaglandins, leukotrienes, and essential fatty acids.

[31]  E. Brahn,et al.  Angiogenesis inhibition suppresses collagen arthritis , 1992, The Journal of experimental medicine.

[32]  S D Prionas,et al.  Dual role of tumor necrosis factor-alpha in angiogenesis. , 1992, The American journal of pathology.

[33]  D. Ingber,et al.  Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. , 1991, Biochemical and biophysical research communications.

[34]  L. Sachs,et al.  Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[36]  R. Saura,et al.  Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. , 1989, Arthritis and rheumatism.

[37]  A. Mantovani,et al.  Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate , 1989, Nature.

[38]  A. Koch,et al.  Inhibition of production of macrophage-derived angiogenic activity by the anti-rheumatic agents gold sodium thiomalate and auranofin. , 1988, Biochemical and biophysical research communications.

[39]  R. Griffiths,et al.  A modified mouse air pouch model for evaluating the effects of compounds on granuloma induced cartilage degradation , 1988, British journal of pharmacology.

[40]  T. Yamada,et al.  Quantitative method for measuring adjuvant-induced granuloma angiogenesis in insulin-treated diabetic mice. , 1986, Journal of pharmacobio-dynamics.

[41]  A. Koch,et al.  Induction of Neovascularization by Activated Human Monocytes , 1986, Journal of leukocyte biology.

[42]  D. Willoughby,et al.  Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. , 1996, Advances in pharmacology.

[43]  D. Cheresh,et al.  Definition of two angiogenic pathways by distinct alpha v integrins. , 1995, Science.

[44]  J. Gamble,et al.  Angiogenesis: models and modulators. , 1995, International review of cytology.

[45]  J. Brown,et al.  The modulation of granulomatous tissue and tumour angiogenesis by diclofenac in combination with hyaluronan (HYAL EX-0001). , 1995, International journal of tissue reactions.

[46]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[47]  R. Auerbach,et al.  Angiogenesis inhibition: a review. , 1994, Pharmacology & therapeutics.

[48]  D. Cheresh,et al.  Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. , 1994, Cell.

[49]  C. J. Dunn,et al.  Angiostatic cortexone‐heparin combination treatment suppresses chronic granulomatous inflammation in mice , 1991 .

[50]  R. Saura,et al.  Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. , 1989, The Journal of clinical investigation.

[51]  S. Nilsson,et al.  Vasodynamic and angiogenic effects of eicosanoids in the eye. , 1989, Progress in clinical and biological research.